Half-year report · HY

Period2026-01-01 → 2026-06-30
Filed2026-08-06
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 39
MetricValuePeriodScopeSource row
Operating income−¥1.4bn2026-01-01 → 2026-06-30Cons.Operating income
Operating income−¥1.0bn2025-01-01 → 2025-06-30Cons.Operating income
Ordinary income−¥1.6bn2026-01-01 → 2026-06-30Cons.Ordinary income
Ordinary income−¥2.9bn2025-01-01 → 2025-12-31Cons.Ordinary income loss (5-year summary)
Ordinary income−¥1.2bn2025-01-01 → 2025-06-30Cons.Ordinary income
Profit before tax−¥1.6bn2026-01-01 → 2026-06-30Cons.Income before income taxes
Profit before tax−¥1.2bn2025-01-01 → 2025-06-30Cons.Income before income taxes
Net income (owners)−¥1.6bn2026-01-01 → 2026-06-30Cons.Profit loss attributable to owners of parent
Net income (owners)−¥2.9bn2025-01-01 → 2025-12-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)−¥1.2bn2025-01-01 → 2025-06-30Cons.Profit loss attributable to owners of parent
Net income−¥1.6bn2026-01-01 → 2026-06-30Cons.Profit loss
Net income−¥1.2bn2025-01-01 → 2025-06-30Cons.Profit loss
Total assets¥12.3bnat 2026-06-30Cons.Assets
Total assets¥5.1bnat 2025-12-31Cons.Assets
Total assets¥3.0bnat 2025-06-30Cons.Total assets (5-year summary)
Total liabilities¥2.7bnat 2026-06-30Cons.Liabilities
Total liabilities¥5.7bnat 2025-12-31Cons.Liabilities
Net assets / equity¥9.5bnat 2026-06-30Cons.Net assets
Net assets / equity−¥630mat 2025-12-31Cons.Net assets
Net assets / equity−¥2.1bnat 2025-06-30Cons.Net assets (5-year summary)
Cash and deposits¥10.9bnat 2026-06-30Cons.Cash and deposits
Cash and deposits¥4.1bnat 2025-12-31Cons.Cash and deposits
Cash & equivalents¥10.9bnat 2026-06-30Cons.Cash and cash equivalents
Cash & equivalents¥4.1bnat 2025-12-31Cons.Cash and cash equivalents
Cash & equivalents¥2.0bnat 2025-06-30Cons.Cash and cash equivalents
Cash & equivalents¥2.0bnat 2024-12-31dCons.Cash and cash equivalents
Operating cash flow−¥2.1bn2026-01-01 → 2026-06-30Cons.Net cash provided by used in operating activities
Operating cash flow−¥2.0bn2025-01-01 → 2025-12-31Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow−¥1.0bn2025-01-01 → 2025-06-30Cons.Net cash provided by used in operating activities
Investing cash flow−¥17m2026-01-01 → 2026-06-30Cons.Net cash provided by used in investment activities
Investing cash flow−¥54m2025-01-01 → 2025-12-31Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥24m2025-01-01 → 2025-06-30Cons.Net cash provided by used in investment activities
Financing cash flow¥8.9bn2026-01-01 → 2026-06-30Cons.Net cash provided by used in financing activities
Financing cash flow¥4.1bn2025-01-01 → 2025-12-31Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow¥1.1bn2025-01-01 → 2025-06-30Cons.Net cash provided by used in financing activities
EPS (basic)¥-39.512026-01-01 → 2026-06-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-892025-01-01 → 2025-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-39.722025-01-01 → 2025-06-30Cons.Basic earnings loss per share (5-year summary)
Equity ratio77.8%at 2026-06-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

All source rows · 410
ItemContextValueUnit
Notes when there is significant changes in amounts of equity (text)InterimDurationText · Plus
Notes segment information etc type1 semi annual consolidated financial statements (text)InterimDurationText · Plus
Description of fact that companys business comprises single segmentPrior1InterimDuration
Original text (Japanese) 当社グループは、細胞治療・再生医療研究開発事業の単一セグメントであるため、記載を省略しております。
Description of fact that companys business comprises single segmentInterimDuration
Original text (Japanese) 当社グループは、細胞治療・再生医療研究開発事業の単一セグメントであるため、記載を省略しております。
Notes financial instruments semi annual consolidated financial statements (text)InterimDurationText · Plus
Notes revenue recognition semi annual consolidated financial statements (text)InterimDurationText · Plus
Notes per share information semi annual consolidated financial statements (text)InterimDurationText · Plus
Notes significant events after reporting period semi annual consolidated financial statements (text)InterimDurationText · Plus
Other information consolidated financial statements etc (text)InterimDurationText · Plus
Information about company which provides guarantee to reporting company (text)FilingDateInstantText · Plus

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2025-12-31pass rounding
balance sheet identityconsolidated 2026-06-30pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2025-12-31pass
statement vs summary · net assetsconsolidated 2026-06-30pass
statement vs summary · net income attributable to parentconsolidated 2025-01-01/2025-06-30pass
statement vs summary · net income attributable to parentconsolidated 2026-01-01/2026-06-30pass
statement vs summary · operating cash flowconsolidated 2025-01-01/2025-06-30pass
statement vs summary · operating cash flowconsolidated 2026-01-01/2026-06-30pass
statement vs summary · total assetsconsolidated 2025-12-31pass
statement vs summary · total assetsconsolidated 2026-06-30pass